NSMCE2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.41400000001013E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.47269999999311E-05 |
Normal-vs-Stage2 |
3.740800E-03 |
Normal-vs-Stage3 |
2.140000E-03 |
Normal-vs-Stage4 |
7.495500E-03 |
Stage1-vs-Stage2 |
1.161230E-01 |
Stage1-vs-Stage3 |
1.301190E-01 |
Stage1-vs-Stage4 |
4.834400E-02 |
Stage2-vs-Stage3 |
8.828200E-01 |
Stage2-vs-Stage4 |
5.713000E-01 |
Stage3-vs-Stage4 |
6.940800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.16750000000998E-06 |
Normal-vs-AfricanAmerican |
5.89939999999789E-05 |
Normal-vs-Asian |
1.610150E-01 |
Caucasian-vs-AfricanAmerican |
9.703200E-01 |
Caucasian-vs-Asian |
3.576200E-01 |
AfricanAmerican-vs-Asian |
3.567800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.26479999999585E-05 |
Normal-vs-Female |
1.8645999999567E-06 |
Male-vs-Female |
6.358300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.196500E-04 |
Normal-vs-Extreme_Weight |
4.30359999999963E-05 |
Normal-vs-Obese |
1.594230E-04 |
Normal-vs-Extreme_Obese |
1.104630E-01 |
Normal_Weight-vs-Extreme_Weight |
7.414200E-01 |
Normal_Weight-vs-Obese |
5.459600E-01 |
Normal_Weight-vs-Extreme_Obese |
7.989000E-01 |
Extreme_Weight-vs-Obese |
7.654600E-01 |
Extreme_Weight-vs-Extreme_Obese |
9.386600E-01 |
Obese-vs-Extreme_Obese |
9.402400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.705520E-02 |
Normal-vs-Age(41-60Yrs) |
1.62120000002375E-06 |
Normal-vs-Age(61-80Yrs) |
2.183100E-04 |
Normal-vs-Age(81-100Yrs) |
3.907900E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.816800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.312030E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.043800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.233790E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.682400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.189000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.247100E-04 |
Normal-VS-Type2 PRCC |
1.22970000004941E-06 |
Normal-VS-KIRP CIMP |
4.805800E-02 |
Normal-VS-Unclassified PRCC |
4.501700E-02 |
Type1 PRCC-VS-Type2 PRCC |
5.802800E-03 |
Type1 PRCC-VS-KIRP CIMP |
3.646600E-01 |
Type1 PRCC-VS-Unclassified PRCC |
9.926400E-01 |
Type2 PRCC-VS-KIRP CIMP |
5.852800E-01 |
Type2 PRCC-VS-Unclassified PRCC |
6.406500E-02 |
KIRP CIMP-VS-Unclassified PRCC |
5.040000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.097700E-03 |
Normal-vs-N1 |
3.582300E-04 |
Normal-vs-N2 |
2.020400E-01 |
N0-vs-N1 |
1.146240E-01 |
N0-vs-N2 |
4.554600E-01 |
N1-vs-N2 |
9.892000E-01 |
|
|